methotrexate has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de-la-Torre, A; Galindo-Mendez, B; Guayacán, CL | 1 |
Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q | 1 |
Acharya, NR; Babu, M; Browne, EN; Kanakath, A; Lee, SM; Porco, TC; Rathinam, SR; Shen, E; Thundikandy, R | 1 |
Fukuda, K; Kondo, Y; Nishida, T; Suzuki, K | 1 |
Aletaha, M; Dehghan, MH; Peyman, GA; Soheilian, M; Yazdani, S | 1 |
1 trial(s) available for methotrexate and Syndrome, VKH (Vogt Koyanagi Harada)
Article | Year |
---|---|
Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
Topics: Adult; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Panuveitis; Uveomeningoencephalitic Syndrome; Visual Acuity | 2016 |
4 other study(ies) available for methotrexate and Syndrome, VKH (Vogt Koyanagi Harada)
Article | Year |
---|---|
Vogt-Koyanagi-Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia.
Topics: Adult; Colombia; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Ophthalmology; Referral and Consultation; Retinal Detachment; Retrospective Studies; Uveomeningoencephalitic Syndrome; Vision Disorders; Visual Acuity | 2018 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Off-Label Use; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2018 |
Chronic noninfectious uveitis associated with Vogt-Koyanagi-Harada disease treated with low-dose weekly systemic methotrexate.
Topics: Adult; Chronic Disease; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Treatment Outcome; Uveitis; Uveomeningoencephalitic Syndrome | 2012 |
Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
Topics: Administration, Oral; Adolescent; Cataract; Cataract Extraction; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Panuveitis; Prednisolone; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Vitrectomy | 2006 |